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Background: Membrane protein research is frequently hampered by the low natural abundance of these proteins
in cells and typically relies on recombinant gene expression. Different expression systems, like mammalian cells,
insect cells, bacteria and yeast are being used, but very few research efforts have been directed towards specific
host cell customization for enhanced expression of membrane proteins. Here we show that by increasing the
intracellular membrane production by interfering with a key enzymatic step of lipid synthesis, enhanced expression
of membrane proteins in yeast is achieved.
Results: We engineered the oleotrophic yeast, Yarrowia lipolytica, by deleting the phosphatidic acid phosphatase,
PAH1, which led to massive proliferation of endoplasmic reticulum (ER) membranes. For all eight tested
representatives of different integral membrane protein families, we obtained enhanced protein accumulation levels
and in some cases enhanced proteolytic integrity in the Δpah1 strain. We analysed the adenosine A2AR G-protein
coupled receptor case in more detail and found that concomitant induction of the unfolded protein response in
the Δpah1 strain enhanced the specific ligand binding activity of the receptor. These data indicate an improved
quality control mechanism for membrane proteins accumulating in yeast cells with proliferated ER.
Conclusions: We conclude that redirecting the metabolic flux of fatty acids away from triacylglycerol- and
sterylester-storage towards membrane phospholipid synthesis by PAH1 gene inactivation, provides a valuable
approach to enhance eukaryotic membrane protein production. Complementary to this improvement in membrane
protein quantity, UPR co-induction further enhances the quality of the membrane protein in terms of its proper folding
and biological activity. Importantly, since these pathways are conserved in all eukaryotes, it will be of interest
to investigate similar engineering approaches in other cell types of biotechnological interest, such as insect
cells and mammalian cells.Background
Membrane proteins play critically important roles in a
huge diversity of physiological processes. However, struc-
tural information on these proteins is scarce because of
the multitude of experimental problems that need to be
overcome to obtain a sufficient quantity of a detergent-
solubilized, stable, homogeneous and monodisperse protein* Correspondence: Nico.Callewaert@dmbr.vib-Ugent.be
†Equal contributors
1Department for Molecular Biomedical Research, Unit for Medical Biotechnology,
VIB, Technologiepark 927, 9052, Ghent, Belgium
2Department of Biochemistry and Microbiology, Laboratory for Protein
Biochemistry and Biomolecular Engineering, Ghent University, K.L.-Ledeganckstraat
35, 9000, Ghent, Belgium
Full list of author information is available at the end of the article
© 2013 Guerfal et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpreparation from which well-ordered crystals for X-ray
structural analysis can be grown. Only few membrane
proteins have a natural abundance that is high enough
to warrant purification from their native source, and
heterologous overexpression is therefore required in most
other cases. The expression systems that have been suc-
cessfully used to produce membrane proteins for structure
determination include mammalian cell lines, insect cells,
bacterial cells and yeast. However, few expression systems
have been specifically designed for the purpose of produ-
cing integral membrane proteins [1]. In part for that rea-
son, only a small minority of membrane proteins can be
readily overexpressed in a biologically active form, and this
remains one of the bottlenecks on the way to a moreLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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analysis. We here report on a eukaryotic endomembrane
synthesis manipulation strategy for the overproduction
of membrane proteins.
As membrane proteins accumulate in the host cell’s
intracellular and plasma membranes, we hypothesized
that by providing a larger cellular membrane surface area
the capacity to accommodate the overexpressed protein
would increase. Many eukaryotic cells can absorb long-
chain fatty acids (FA) and store them in cytoplasmic lipid
droplets in the form of triacylglycerols (TAG) and steryl
esters (SE) [2]. The uptake of fatty acids from the culture
medium can also directly provide the precursors neces-
sary for phospholipid synthesis and could facilitate the
biogenesis of membranes, if their incorporation into
TAG and SE lipid stores could be suppressed. Thus, our
attention was drawn to PAH1, which encodes phospha-
tidic acid phosphatase Pah1p and which is a gate keeperFigure 1 Schematic presentation of the major steps in phospholipid b
PAH1, catalyzes the dephosphorylation of PA to DAG, the precursor of the
this activity in yeast, but only PAH1 is involved in the synthesis of TAG and
derived from PA, with the exception of phosphatidylinositol which needs e
TAG, triacylglycerol; PI, phosphatidylinositol; CL, cardiolipin; PS, phosphatidyfor directing the flux of FA into TAG [3]. In PAH1-
deleted Saccharomyces cerevisiae, phosphatidic acid (PA)
cannot be converted to diacylglycerol (DAG) and, con-
sequently, no TAG can be made via the Pah1 pathway
(Figure 1). Informed by the massive ER/nuclear mem-
brane proliferation seen in a Δpah1 strain of S. cerevisiae
[4] we investigated whether we could utilize this Δpah1
phenotype to enhance membrane protein productivity.
We chose to work with Yarrowia lipolytica because fatty
acid-regulated promoters are well established for this
organism [5] and we hypothesized that the ability to
feed direct precursors for membrane lipids (i.e. fatty acids)
would be most suitable to achieve enhanced membrane
lipid biosynthesis.
As our previously reported data in Pichia pastoris
indicated that co-induction of the unfolded protein re-
sponse (UPR) can enhance membrane protein homogen-
eity and activity [8], we also evaluated the combinediosynthesis in yeast [6]. Phosphatidic acid phosphatase, encoded by
storage lipid TAG (there are 3 more genes coding for enzymes with
the regulation of phospholipid synthesis [7]). All phospholipids can be
xogenous inositol input. PA, phosphatidic acid; DAG, diacylglycerol;
l-serine; PE, phosphatidylethanolamine; PC, phosphatidylcholine.
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eration and UPR induction on the quantity and quality
of the heterologously expressed membrane proteins.
Results
Identification and knockout of the Yarrowia lipolytica
PAH1 gene
The sequence of the PAH1 gene of Y. lipolytica was
identified through a homology search with the Saccharo-
myces cerevisiae PAH1 gene (GeneID: 855201) against
the genome of Y. lipolytica, using the Basic Local Align-
ment Search Tool (Blast) from NCBI. The Blast analysis
identified the protein YALI0_D27016p, which shows some
similarities to the nuclear elongation and deformation
protein 1 of Schizosaccharomyces pombe, the S. pombe
orthologue of Pah1p [9]. The sequence contains the
conserved HAD-like domain with a DxDxT motif, in
the middle of the protein sequence [10]. The family-
characteristic N-terminal lipin domain was also identi-
fied (Additional file 1: Figure S1A).
A knockout construct for PAH1 was made (Additional
file 1: Figure S1B) to replace the PAH1 coding sequence
by the sequence of the LEU2 selection marker [11]. The
knockout was confirmed by PCR on genomic DNA
(Additional file 1: Figure S1C).
Impact of PAH1 deletion on Yarrowia lipolytica growth
As our purpose was to use the Δpah1 strain for the
large-scale production of membrane proteins, it was
important to evaluate the impact of the Δpah1 muta-
tion on the growth characteristics of the strain on glucose
and oleic acid, the two carbon sources used for protein
production with Y. lipolytica. Growth curves for the wild
type and the Δpah1 strain were generated. Compared to
the wild type control, growth of the mutant strain was
only slightly retarded on glucose, and only during the
early exponential phase (Figure 2A). Cells grown on oleicFigure 2 Evaluation of the Δpah1 growth phenotype. The growth phe
on glucose and oleic acid as carbon sources. The empty vector strain (EV) i
LEU selection marker cassette to rule out any effect of the selection pressu
LEU selection marker on the knockout construct. A. Growth on glucose as
slightly and in the stationary phase, cells reached the same OD600 as the w
Also here, the PAH1 knockout strain has a prolonged lag phase but it reachacid went through a longer lag phase but reached the
stationary phase at the same optical density as the wild
type strain (Figure 2B). These results show that the mu-
tation does not appear to have a major impact on overall
cellular physiology and does not present a serious obs-
tacle to the utility of the strain for recombinant protein
production.
Membrane protein expression in the Δpah1 and
Δpah1/Hac1p strain
To begin to evaluate the impact of this lipid synthesis
engineering step on the obtainable expression levels
of heterologous integral membrane proteins, we chose
to study the Adenosine A2A receptor (A2AR) that belongs
to the pharmacologically highly interesting family of G-
protein coupled receptors (GPCRs). Radioligand binding
assays are available to evaluate the functionality of the
protein [12]. First, we generated a wild type Y. lipolytica
strain expressing the A2AR from a single integrated gene
copy under control of the oleic acid-inducible POX2
promoter. We then generated a Δpah1 derivative of this
strain, ensuring that the wild type and Δpah1 strains
expressed the A2AR in the same genetic background.
Furthermore, we studied whether this Δpah1 membrane
capacity engineering could be usefully integrated with a
concomitant enhancement of the ER protein quality
control capacity as afforded by induction of the un-
folded protein response. The UPR in yeast is triggered
by non-canonical splicing of the HAC1 mRNA [13]. We
identified the splice event in Y. lipolytica (as also identi-
fied since in [14]) and generated an expression con-
struct for the spliced active Yarrowia HAC1, driven by
the POX2 promoter. Subsequently, both the wild type
and the Δpah1 A2AR-expressing strains were transformed
with this expression vector.
The expression levels of A2AR in the different strains
were determined by western blot analysis (Figure 3A).notype of an empty vector strain and the Δpah1 strain was compared
s the PO1d ΔOCH1 strain transformed with a plasmid containing the
re, compared to the PAH1 knockout strain (Δpah1), which carries the
carbon source for 27 hours. Growth of the knockout was retarded only
ild type strain. B. Growth on oleic acid as carbon source for 55 hours.
es the stationary phase at the same OD600 as the empty vector strain.
Figure 3 Analysis of A2AR expression and membrane expansion in the Δpah1 strain. A. Western blot analysis of A2AR in 10 μg of total
membrane proteins of wild type, Δpah1, HAC1 co-overexpression and Δpah1/Hac1p strains. B. Radioligand binding studies on membranes expressing
the A2AR. Deletion of the PAH1 gene leads to a strong increase (over 20-fold) in production of ligand-binding receptor. Artificial induction of the UPR
reduces the quantity of receptor produced, but strongly enhances the radioligand binding activity, indicating enhanced receptor protein quality.
C. EM pictures were taken after 48 hours growth on oleic acid of both wild type and Δpah1 cells. When the knockout cells are grown on oleic
acid, whirls and stacked layers of proliferated membrane become apparent. Also, few or no lipid droplets are present in the knockout strain, while
big droplets are present in the wild type cells (arrows). D. HPLC-LSD analysis of the major cellular lipid classes derived from the strains grown on
oleic acid. Lipid levels were quantified relative to those in the wild type parental strain (represented as 100%, broken horizontal line). The values
derived from two independent experiments are shown, with their average represented by the short horizontal lines.
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strongly enhanced the expression levels of the GPCR.
qPCR analysis showed that the mRNA levels for the
GPCR were only slightly enhanced in the Δpah1 strain
(non-significant, P = 0.083, Mann-Whitney U-test, n = 8)
(Additional file 2: Figure S2), indicating that stronger
promoter activation and/or altered mRNA metabolismin the knockout is not the main causative factor for the
strongly enhanced membrane protein accumulation. The
Δpah1/Hac1p combination strain showed a somewhat
lower production yield of the A2A receptor than the
Δpah1 strain (Figure 3A). We next performed A2AR lig-
and binding studies on total membrane protein extracts
to study whether the enhanced receptor expression levels
Figure 4 Expression analysis of seven other membrane
proteins in the wild type and Δpah1 strain. Membrane protein
expression, under control of the POX2 promoter for induction on
oleic acid, was performed for 24 hours and 10 μg of total
membrane proteins was analysed by western blot. For all seven
membrane proteins tested, a moderate to strong enhancement of
protein yield was observed. In some cases (Bap31 and NS4) there
was also a reduced proteolysis of the protein. 5HT1D, 5-hydroxytryptamine
1D receptor; Mu, mu opioid receptor; Aquap, aquaporine Aqy1; Bap31,
B-cell associated receptor 31; NS4, non-structural protein 4; Presen,
presenilin; CytP450, cytochrome P450; WT, wild type; Δ, Δpah1 strain.
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competent receptor (Figure 3B). Under our test condi-
tions, no binding of the ligand was detectable in the wild
type POX2-A2AR strain, whereas in the derived Δpah1
strain, Bmax was 1178 ± 81 fmol per mg of total membrane
protein. The lack of detectable ligand binding in the wild
type strain was most likely due to the very low expression
level of the receptor or its poor folding, or both.
Although the protein expression levels were similar
in the Δpah1 and Δpah1/Hac1p combination strains,
we observed almost 2-fold increased specific radioli-
gand binding activity of the receptor when Hac1p was
co-overexpressed (2167 ± 65 fmol per mg of total mem-
brane protein). We speculate that this is due to enhanced
ER-chaperone mediated folding. In addition, enhanced
ER associated degradation (ERAD) may aid in degrading
molecules that are not folded in a ligand-binding com-
petent state.
We also assessed intracellular membrane morphology
in the wild type and Δpah1 strains by electron micros-
copy (EM) of cells cultivated to high cell density (which
is relevant for heterologous protein production) on oleic
acid (Figure 3C). Wild type cells growing on oleic acid
massively overproduce TAG, which is stored in cytosolic
lipid droplets. In stark contrast, EM analysis of the Δpah1
strain revealed massive intracellular membrane prolifera-
tion and almost complete absence of lipid droplets. This
observation is consistent with the metabolic function of
Pah1p to regulate the flux of phosphatidic acid into TAG
synthesis.
The enhanced lipid fluxes towards membrane lipids
in the Δpah1 Y. lipolytica strain grown on oleic acid
were confirmed by HPLC-light scattering detection
analysis of cellular lipid content and composition (Figure 3D):
in the Δpah1 mutant, the TAG pool was reduced ap-
proximately 5-fold, and the SE pool was reduced about
2-fold as compared to the wild type strain, whereas the
levels of the membrane lipids ergosterol (ERG), phos-
phatidylethanolamine (PE) and phosphatidylcholine (PC)
were all increased about 2-fold. The levels of phos-
phatidylinositol were similar to the wild type strain.
HAC1 overexpression in the Δpah1 background did not
alter this lipid composition, excluding the possibility
that the HAC1 overexpression effect on membrane
protein quality was due to membrane lipid alterations
(Figure 3D).
The Δpah1 mediated membrane protein overexpression
is broadly applicable
To explore whether the massive intracellular membrane
expansion seen in the Δpah1 strain was specific to A2AR
or had a beneficial effect on membrane protein yield and
function in general, we studied expression of seven add-
itional integral membrane proteins: the human 5HT1Dreceptor, human mu opioid receptor, aquaporin Aqy1
of Pichia pastoris, human B-cell associated receptor 31,
porcine respiratory virus (PRV) NS4, presenilin/SPP
homologue of Methanoculleus marisnigri JR1, and human
cytochrome P450 2D6. For all of these proteins, as for
the A2AR described above, we first generated expressing
clones and then knocked out PAH1 in all of these
strains. While significantly expanding the effort, this
approach ascertains that differences in protein expres-
sion between the wild type and the mutants are not
due to e.g. differences in transgene insertion site or
copy number. All of the expressed membrane proteins
in our analysis show a moderate to strong increase in
the expression level in the Δpah1 strain. In cases where
proteolysis occurred in the wild type strain, this was much
less the case in the Δpah1 strains, for example for Bap31
and PRV NS4 (Figure 4). Thus, we conclude that deletion
of the PAH1 gene and enhanced membrane production
in the presence of oleate provides a viable and widely
applicable strategy for membrane protein expression.
Discussion
In the last few years, several breakthroughs have been
achieved in the ability to stabilize membrane proteins
(especially GPCRs) by engineering the molecules them-
selves; these strategies have yielded several crystal struc-
tures of those membrane proteins that express relatively
well in standard expression systems [15,16]. Together with
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systems for integral membrane proteins, such as described
here, will allow access to a much broader spectrum of
membrane proteins than has been possible to date.
In the Δpah1 strain, the cells are severely impaired in
neutral lipid synthesis and consequently showed a strong
reduction or absence of lipid droplets, which was also
reported for S. cerevisiae [3]. The absence of this lipid
droplet sink for fatty acids, makes the strain potentially
susceptible to fatty-acid induced lipotoxicity. Indeed, the
mutant strain showed a somewhat extended lag phase
compared to wild type cells, however, it readily adapted
to the presence of excess oleic acid and grew to similar
cell densities as the wild type strain, in stationary phase.
Although S. cerevisiae strains defective in neutral lipid
synthesis (Δare1 Δare2 Δdga1 Δlro1) also show an ex-
tended lag phase on oleic acid and eventually reach wild
type levels of cell density [17], this adaptation is likely
due to second site suppressors [18]. Thus, Yarrowia – an
oleaginous yeast – is much more tolerant to alterations
in fatty acid fluxes. In any case, since a similar culture
density is obtained with the Yarrowia Δpah1 strain as
with the wild type, this strain is entirely suitable for bio-
technological protein production. All work reported here
is based on simple shake flask cultivation with single-
copy strains, thus, further strategies to enhance the yield
of the strains developed in this study include optimal
oleic acid feeding in controlled bio-fermentors, and
exploring the effect of gene copy number increases. In
addition, newer generations of stronger promoters for
Yarrowia have recently been described [19,20] and will
be useful to enhance the obtainable expression levels.
Importantly, the unfolded protein response and the
master lipid flux regulatory role of Pah1p orthologues
(lipins) [21], are conserved in all eukaryotes, including
insect cells and mammalian cells. Technology to knock
down or knock out genes in these organisms is now
readily available [22,23]. Therefore, there is scope for
applying the same membrane engineering approach to
these other frequently used (membrane) protein expres-
sion hosts. However, careful exploration of an appropri-
ate match between the carbon source and the promoter
systems will be required for other biotech cell types in
which the Δpah1 manipulation is attempted and this
will be the subject of further studies. For example, while
Pichia pastoris is widely used for heterologous protein
expression and extremely strong methanol-inducible
promoters are available, our preliminary data (unpub-
lished) suggest that C1-metabolism is not compatible
with Δpah1-mediated membrane expansion: the mem-
branes appear to be autophagocytosed, obliterating any
beneficial effect on membrane protein expression yields.
However, the rapidly expanding genetic toolbox for
Pichia [24] will allow to match appropriate promotersystems with carbon source feeding strategies that allow
for Δpah1-mediated stable membrane surface expansion.
Conclusions
We conclude that Δpah1-mediated redirection of lipid
synthesis fluxes away from storage lipids and towards
membrane lipids, leads to a strong intracellular mem-
brane proliferation especially when the cells are fed with
fatty acids. This membrane expansion affords enhanced
expression levels and proteolytic integrity of integral
membrane proteins. We furthermore conclude that co-
induction of the UPR in such Δpah1 strains improves
the quality of the overproduced membrane proteins. The
engineered pathways are conserved in all eukaryotes,
which offers a scope for application in other yeasts, in-
sect cells and mammalian cells. To our knowledge, this
is the first successful attempt to engineer the membrane
synthesis machinery of a eukaryotic expression system to
customize cells for accommodating integral membrane
proteins. The improved yield, stability and activity of
membrane proteins in these mutant strains are likely
to enhance progress on their functional and structural
characterization.
Methods
Strains
E. coli MC1061 was used for standard molecular biology
manipulations. E. coli was grown in LB medium supple-
mented with the appropriate selection antibiotics. Yarrowia
lipolytica PO1d ΔOCH1 was used for analysis and protein
expression. This strain is a knockout for the OCH1 manno-
syltransferase in the wild type PO1d strain (CLIB 139),
which results in the absence of N-glycan hyperman-
nosylation, which is beneficial for more homogenous
glycoprotein production [25].
Transformation
Transformation was performed by the lithium acetate
method as described by Barth and Gaillardin [26].
Generation and identification of a PAH1 knockout strain
A PAH1 knockout strain was generated according to the
protocol described by Fickers et al. [11] and as depicted
in Additional file 1: Figure S1B. Genomic DNA was iso-
lated using the MasterPureTM Yeast DNA Purification
Kit according to the manufacturer’s instructions (Epicentre
Biotechnologies, WI, USA). Clones that were prototro-
phic for leucine were then genotyped by PCR with primers
pah1ylPfw07-010 (5′-GCGGCCGCGAAGACGGTGAG-
TATGGCCATC-3′) and pah1ylTrv07-007 (5′-GCGGCC
GCCCAAACCATGCATACAAATCAG- 3′. PCR was
performed with Phusion polymerase (Thermo Scientific,
MA, USA): 5 min at 98°C, followed by 25 cycles of 1
min at 98°C, 20 sec at 60°C, and 45 sec at 72°C. A band
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band of 2966 bp for the Δpah1 strain. Random integra-
tion would lead to the presence of both bands.
Cloning of spliced form of Y. lipolytica HAC1 and
construction of Hac1p expression plasmid
The spliced form of HAC1 mRNA from Y. lipolytica
PO1d was isolated as described earlier [8]. In brief, UPR
was induced by adding DTT to 5 mM to an exponen-
tially growing culture. RNA was isolated and reverse
transcribed as described. The spliced cDNA was cloned
into the BamHI/AvrII sites in plasmid JMP62hyg, which
is a Yarrowia expression vector containing the POX2
promoter and a hygromycin resistance cassette. The result-
ing plasmid is called JMP62hygHAC1(s). The plasmid was
cut with KpnI before transformation to allow integration
in the POX2 promoter locus.
Construction of the membrane protein expression vectors
The coding sequence of the Adenosine A2A receptor
was isolated from a fetal brain cDNA library with
primers 5′-GAATGCAATGCCCATCATGGGCTCC-3′
and 5′-CCTAGGTCAAGCTGGAGCAACTTGAGAAG-
3′, which include the BsmI and AvrII restriction sites. The
isolated gene was cloned in the pCR®-Blunt II-TOPO vec-
tor (Invitrogen). The insert in the resulting vector pTO-
POA2A was sequence-verified. The open reading frame
was then cloned in the vector pYLPUXdl2prepro, which
contains a ura3d1 selection marker, the POX2 promoter
and the secretion signal of the LIP2 gene for fusion to the
coding sequence of the protein of interest. To obtain the
construct expressing the A2A receptor from the POX2
promoter, this vector was cut with FseI and AvrII. The
coding sequence of the A2A receptor was isolated from
the pTOPOA2A vector by BsmI/AvrII digestion. The
appropriate fragments were ligated and the final plasmid
was called pPOX2-A2A. The genes of the seven other
membrane proteins, fused to the LIP2 secretion sig-
nal, were produced using synthetic DNA technology
(GenScript, NJ, USA) with terminal BamHI/AvrII re-
striction sites for cloning into the pYLPUXdl2prepro
backbone.
Growth curve
To analyse the growth phenotype of the PAH1 knockout
strain, a comparison was made with an empty vector
(EV) strain. This EV strain is the PO1d ΔOCH1 strain
transformed with a NotI-linearized plasmid, pJMP62LEU,
containing the LEU selection marker cassette, making
this strain leucine-prototrophic, as the knockout strain.
Cultures were grown overnight to saturation in YPD
(1% yeast extract, 2% peptone, 2% dextrose) or YTO
(50 mM phosphate buffer pH 6.8, 1% yeast extract, 2%
tryptone, 2% oleic acid) and diluted the next day to anOD600 of 0.2. Incubation was continued and OD600
was measured periodically. For the cultures grown on
medium containing oleic acid, the cells were spun down
for 10 minutes at 13,000 rpm and washed once with 0.1N
NaOH to avoid interference of oleic acid in the OD600
measurement. Samples were measured in triplicate.
Small scale expression
Induction experiments for the Adenosine A2A receptor
were performed in 12.5 ml of culture medium in a 125-ml
baffled flask, for the other membrane proteins, induction
was performed in 2 ml of culture medium in 24 deep well
plates. For all experiments, an overnight pre-culture was
used to inoculate medium to an OD of 0.1. Cells were
grown for 24 hours in YTD (1% yeast extract, 2% tryptone,
2% dextrose), washed once with water, and then resus-
pended in induction medium (50 mM phosphate buffer
pH 6.8, 1% yeast extract, 2% tryptone, 2% oleic acid). Cells
were cultivated for another 24 hours before harvesting.
Membrane protein preparation
Cells (approximately 12 × 108 cells) were pelleted by
centrifugation at 1,500 × g and the pellet was resuspended
in ice-cold disruption buffer (50 mM sodium phosphate
buffer pH 7.4 supplemented with Complete protease
inhibitor cocktail (Roche)). Cells were then broken by
vigorous vortexing with glass beads in a mixer mill for
5 x 2 min at 4°C. Cell debris was separated from the mem-
brane suspension by low speed centrifugation (1,000 × g,
30 min, 4°C). Total cellular membranous organelles
were pelleted at 100,000 × g at 4°C for 60 min. For all
membrane proteins analysed in Figure 4, the ultracen-
trifugation step was substituted for centrifugation at
13,000 × g at 4°C for 60 min, as this was found not to be
required to enable western blot analysis, and to yield very
similar results as the protocol involving ultracentrifuga-
tion. The membranous pellet was resuspended in 50 mM
sodium phosphate buffer pH 7.4 supplemented with
Complete protease inhibitor cocktail and snap-frozen in
liquid nitrogen until further testing. The protein concen-
tration of the membrane preparation was determined
using the BCA reagent (Pierce, Rockford, IL) with BSA as
a standard. Ten micrograms of total membrane protein
were analyzed by western blot. The blot was blocked over-
night in 0.05% Tween-20 and 3% casein in 1x PBS and
probed with a 1/500 diluted primary mouse anti-Rho1D4
antibody, followed by a 1/3000 diluted secondary anti-
mouse IgG peroxidase from sheep (Sigma Cat. n° NA931V).
Protein bands were visualized with Renaissance western
blot Chemiluminescence Reagent Plus (PerkinElmer).
Ligand binding of Adenosine A2A receptor
The procedures for studying binding to recombinant
A2A receptors have been described [12]. Briefly, 10 μg of
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concentrations of the A2AR antagonist, [3H]ZM241385
(0.05-12 nM), in 500 μl of binding buffer (20 mM
HEPES pH 7.4, 100 mM NaCl). Adenosine deaminase
(0.1 U) was added to degrade the adenosine released
from the membranes, and the membranes were incubated
at 22°C for 1 hour. Non-specific binding was determined
in the presence of 10 mM theophylline. Measurements
were performed in duplicate. After incubation, bound and
free ligands were separated on Whatmann GF/B filters
pretreated with 0.1% polyethylenimine using a Brandel cell
harvester. The filters were washed three times with bind-
ing buffer and the amount of bound radioligand was
measured on a liquid scintillation counter. Kd and Bmax
were determined by rectangular hyperbole curve fitting
using KaleidaGraph software (Synergy Software).
Electron microscopy
Samples were prepared for EM according to Baharaeen et al.
[27]. Yeast cells were fixed for 2 h on ice in 1.5% parafor-
maldehyde and 3% glutaraldehyde in 0.05 M sodium caco-
dylate buffer, pH 7.2. After washing three times for 20 min
in buffer, cells were treated with a 6% aqueous solution of
potassium permanganate for 1 h at room temperature, to
enhance membrane contrast. After washing three times
for 20 min in buffer, cells were dehydrated through a graded
ethanol series, including bulk staining with 2% uranyl
acetate at the 50% ethanol step, followed by embedding in
Spurr’s resin. Ultrathin sections of a gold interference
colour were cut using an ultra microtome (Ultracut E;
Reichert-Jung), post-stained with uranyl acetate and lead
citrate in a Leica ultrastainer, and then collected on formvar-
coated copper slot grids. They were viewed with a trans-
mission electron microscope 1010 (JEOL, Tokyo, Japan).
Reverse transcription quantitative PCR
Eight biological replicates of both the wild type strain
and the PAH1 deletion strain were grown and induced
as described above. After 24 hours of induction, 6.10E8
cells were pelleted and washed twice with 0.1M NaOH
at room temperature to completely remove oleic acid.
Total RNA was prepared using the RiboPure yeast kit
(Ambion, Life Technologies) according to the manu-
facturer’s protocol. 10 μg of total RNA was submitted
to DNase treatment using the TURBO DNA-free kit
(Ambion, Life Technologies). RNA integrity was con-
firmed for all sixteen samples using the Agilent RNA
6000 Pico Kit on the BioAnalyzer 2100 (Agilent Technolo-
gies). cDNA was prepared from 2 μg DNase-treated RNA
using the iScript Synthesis Kit (BioRad) and a control
reaction lacking reverse transcriptase was included for
each sample. The RT-PCR program was as follows:
10 minutes at 25°C, 30 minutes at 42°C, 5 minutes at
85°C, and then cooling down to 12°C.Real time quantitative PCR was done on a LightCycler
480 (Roche Diagnostics) using the SensiFast SYBR-NoRox
kit (BioLine), in triplicate for each RNA sample, on a
384-multiwell plate, with 5% cDNA in a total volume
of 10 μL. Primers were used at a final concentration of
10 μM. All primer pairs were generated using PrimerBlast
(http://www.ncbi.nlm.nih.gov/tools/primer-blast) and veri-
fied for cross-specificity within the Yarrowia genome, as
well as optimized for reduced secondary structure for-
mation and reduced duplex formation. Primers used in
the final experiment can be found in Additional file 3:
Table S1. The following programme for cDNA synthesis
was used: 3′ at 95°C, and 45 times 3″ at 95°C - 30″ at
60°C - 1″ at 72°C. The necessary controls (no reverse
transcriptase controls, no template controls) were in-
cluded. The stability of 10 candidate reference genes
for normalization was analyzed in a pilot experiment
(data not shown) using the genormPLUS algorithm, as
implemented in the qbasePLUS software [28]. Based on
these results, all gene expression values were normalized
using the geometric mean of the genes PGK (Gene ID:
2910137) and QCR9 (Gene ID: 2906637). Determination
of amplification efficiencies and conversion of raw Cq
values to normalized relative quantities (NRQ) were per-
formed using the the qbasePLUS software [28]. Statistical
analyses of NRQs were done with the Prism 6 software
package using the Mann-Whitney U-test.Lipid extraction
Lipid extraction of wild type, PAH1 knockout, Hac1p
overexpressing and Δpah1/Hac1p strains was performed.
After cultivation as described above, cells correspond-
ing to 20 OD600 units were harvested and disrupted
with glass beads in chloroform/methanol 2:1 (v/v), by
shaking in a Heidolph Multi Reax test tube shaker
(Schwabach, Germany). Lipids were extracted accord-
ing to Folch et al. [29].HPLC-LSD
The chromatographic setup consisted of an Agilent
1100 combining pump, injector, precooled sample man-
ager (4°C) and column oven (40°C). For detection of the
lipids, a Sedex 85 evaporative light scattering detector
(Sedere, France) was used. Data acquisition was per-
formed by the Chemstation software (B 04.01). A ternary
gradient (modified from [7]) with a Betasil Diol column
(100 × 4.6 mm, particle size 5 μm, Thermo) was used to
separate the various lipid classes. Neutral lipid stan-
dards were purchased from Larodan, except for ergos-
terol (Acros Organics) and cholesterylpalmitate (Sigma
Aldrich). Neutral lipid and phospholipid (Avanti Polar
Lipids) standards were prepared as 1 mg/ml stock solu-
tions in chloroform/methanol 2:1 (v/v). Calibration curves
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Additional files
Additional file 1: Figure S1. Yarrowia lipolytica PAH1 gene and
PAH1-knockout generation. A. Domain structure of the Pah1 protein,
where the conserved N-lipin domain is shown in green. The asterix
represents the conserved glycine residue, which, together with the
aspartic acid residues in the HAD domain (orange), is necessary for
the phosphatidic acid phosphatase activity of Pah1p. B. Knockout
strategy used to delete the PAH1 gene. Integration of the knockout
cassette replaces the PAH1 gene by the LEU2 selection marker. The
strategy for knocking out the PAH1 gene was set up as described in
Fickers et al. [11]. We generated a construct that includes the promoter and
terminator fragment of the PAH1 gene and a LEU2 marker for selection. A
knockout is obtained after double homologous recombination at the
promoter and terminator sites of PAH1. C. After transformation with the
PAH1 knockout construct (P-LEU2-T), transformants were isolated and
genotyped for the PAH1 gene locus. Lane 1, 1 kb DNA marker (Promega).
Lanes 2 and 3, PCR amplificate of the PAH1 gene locus in, respectively, the
wild type PO1d strain and an empty vector plasmid strain (expected wild
type PAH1 amplificate size is 3268 bp). Lane 4, PCR amplificate of the
disrupted PAH1 gene locus in a knockout strain (expected amplificate
size is 2966 bp).
Additional file 2: Figure S2. Adenosine A2A transgene mRNA
expression in the wild type and PAH1 deletion strains. Graph showing the
normalized relative quantities of the adenosine A2A receptor transgene
mRNA in the wild type and PAH1 deletion strains. A trend towards more
transgene mRNA in the knockout strain can be observed, which however
did not reach statistical significance (p = 0.083), even with 8 biological
replicates. (Mann-Whitney U-test). Horizontal bars represent median with
the interquartile ranges.
Additional file 3: Table S1. qPCR primers of protein-coding genes.
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